1st Quarter - Report

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$192,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 16, 2012 $192,000 Replaced
1st Quarter - Amendment Apr 4, 2014 $192,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule; the oversight of laboratory-developed tests, HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control Act of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 3630, the Middle Class Tax Relief and Job Creation Act of 2012 (PL 112-96)

LobbyistCovered position, as disclosed
JASON DUBOIS Vice President, Government Relations
JO ANNE GLISSON Senior Vice President
JENNIFER BULLARD MADSEN Vice President, Policy and Medical Affairs
SCOTT VAN BUREN MCGOOHAN New Director, Regulatory and Reimbursement Affairs
ALAN MERTZ President
DAVID ALAN MONGILLO Vice President, Policy and Medical Affairs
FRANCESCA FIERRO O'REILLY Vice President, Government Relations

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3207 (112th), H.R. 3630 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.